Eslicarbazepine acetate: An efficacy and safety as an antiepileptic drug in clinical trials and open studies
Eslicarbazepine acetate (Zebinix®, ESL), a voltage-gated sodium channel blocker, is a once-daily, orally administered anti-seizure medication available in the EU for use as monotherapy in adults with newly diagnosed partial-onset seizures and as adjunctive therapy in adults, adolescents, and childr...
Furkejuvvon:
| Váldodahkkit: | , , , , , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
Kazimierz Wielki University
2022-02-01
|
| Ráidu: | Journal of Education, Health and Sport |
| Fáttát: | |
| Liŋkkat: | https://apcz.umk.pl/JEHS/article/view/37376 |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|